We are excited to launch the 2025 APBD Tour de Friends Rally for Research Fundraising Campaign to raise $150,000.*
In spite of the challenging economic climate, we are committed to raising funds to advance APBD research. Through May 16, your gift can have double the impact thanks to our generous Board’s dollar-for-dollar match, up to $50,000.
Since our founding in 2005, we have raised and awarded over $1.8 million in pilot research grants as a Foundation and through UPenn’s MDBR. Recipients include researchers at Columbia University, Duke University Medical Center, UT Southwestern Medical Center, University of Florida, Newcastle University, and Hadassah Medical Organization.
These seed grants have made possible the ground-breaking drug discovery and biomarker development initiatives that are progressing today. To advance these initiatives — bring therapies from the bench to our patients — we must continue to invest in research.
The APBD Tour de Friends Rally for Research campaign replaces the UPenn MDBR campaign with which we have partnered since 2016. Through June 30, we invite you to join Team APBD Tour de Friends and our broader community as we raise money for life-saving APBD research.
Since our founding in 2005, we have raised and awarded over $1.8 million in pilot research grants as a Foundation and through UPenn’s MDBR. Recipients include researchers at Columbia University, Duke University Medical Center, UT Southwestern Medical Center, University of Florida, Newcastle University, and Hadassah Medical Organization.
These seed grants have made possible the ground-breaking drug discovery and biomarker development initiatives that are progressing today. To advance these initiatives — bring therapies from the bench to our patients — we must continue to invest in research.
The APBD Tour de Friends Rally for Research campaign replaces the UPenn MDBR campaign with which we have partnered since 2016. Through June 30, we invite you to join Team APBD Tour de Friends and our broader community as we raise money for life-saving APBD research.